** Shares of cannabis firms fall as U.S. Drug Enforcement Administration (DEA) judge on Monday cancelled marijuana rescheduling hearings
** Tilray Brands TLRY.O falls 1.5% and Cresco Labs CL.CD down 3.8%
** Toronto-listed shares of Canopy Growth WEED.TO down 2%, Trulieve Cannabis TRUL.CD falls 2.7% and Curaleaf Holdings CURA.TO down 3.2%
** John Mulrooney, the DEA administrative law judge, cancelled the scheduled January 21 merit-based hearing and stayed the proceedings for at least three months
** Despite marijuana being legal in dozens of U.S. states, federal law categorizes it as a schedule I drug and prohibits most conventional U.S. banks from doing business with cannabis firms
(Reporting by Pooja Menon in Bengaluru)
((Pooja.Menon@thomsonreuters.com;))